{"id":"W4220704364","doi":"10.1016/j.annonc.2022.03.003","title":"Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study","year":2022,"lang":"en","type":"letter","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Partnership Against Cancer; University of Calgary","funders":"Dana-Farber Cancer Institute","keywords":"Medicine; Tamoxifen; Breast cancer; Oncology; Internal medicine; Adjuvant therapy; Adjuvant; Population; Endocrine system; Letrozole; Gynecology; Aromatase inhibitor; Cancer; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003459419,0.0003740234,0.001708809,0.000644966,0.0004095919,0.001473356,0.000617773,0.002585862,0.001515705],"category_scores_gemma":[0.005971017,0.000338262,0.0008463523,0.001067316,0.0004206023,0.0007972737,0.0003459918,0.003240032,0.0009748547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001979127,"about_ca_system_score_gemma":0.00154172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002432426,"about_ca_topic_score_gemma":0.01407161,"domain_scores_codex":[0.9986038,0.0004403861,0.0002017417,0.0001130416,0.0004647794,0.0001762563],"domain_scores_gemma":[0.9954244,0.002448365,0.0005472688,0.0002562002,0.0007875179,0.0005361056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01902132,0.0006200353,0.0607469,0.001139534,0.001302497,0.004661172,0.0001901861,0.0007802734,0.004569602,0.001413389,0.5125782,0.3929769],"study_design_scores_gemma":[0.01367846,0.004980775,0.2113975,0.001316269,0.003913662,0.0101838,0.0004814435,0.00208478,0.003365404,0.007054045,0.7413397,0.0002041483],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1633685,0.1057147,0.0007930676,0.6621355,0.02037432,0.0002243237,0.009872918,0.000184901,0.03733188],"genre_scores_gemma":[0.3737481,0.04232818,0.002205976,0.5110121,0.0441015,0.0002544466,0.00640476,0.000152355,0.01979265],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.003459419,"threshold_uncertainty_score":0.01829541,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04882049634006941,"score_gpt":0.3642995035609408,"score_spread":0.3154790072208714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}